NR4A1 and breast carcinoma: Since endocrine targeted therapies can effectively prevent hormone receptor positive breast cancer and other nuclear receptor targets have been shown to prevent hormone receptor negative BC, it is reasonable that combination treatments for the prevention of breast cancer should be explored.